Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CHE · against 205 other Healthcare companies of similar size
Ranked #121 of 206 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 40–49, including CHE · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | CHE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 203 reported | 3.8% | 2.5% | 67% | 30% | |
| EBITDA yieldHigher is better · 205 reported | 5.8% | 4.6% | 59% | 50% | |
| Free cash flow yieldHigher is better · 120 reported | 5.4% | 1.2% | 85% | 20% | |
| Book yieldHigher is better · 204 reported | 12.0% | 23.6% | 27% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 116 | 10.8B USD | 49 | 35 | |
| 118 | 34.2B CNY (≈$4.8B) | 48 | 59 | |
| 118 | 7.2B USD | 48 | 43 | |
| 118 | 12.3B USD | 48 | 35 | |
| 121 | 7.0B USD | 47 | 63 | |
| 121 | 596.9B INR (≈$7.2B) | 47 | 58 | |
| 123 | 5.76T KRW (≈$4.1B) | 46 | 59 | |
| 123 | 81.4B CNY (≈$11.4B) | 46 | 55 | |
| 123 | 11.4B USD | 46 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score